StonvexLoading…
StonvexStonvexStonvexCore line items from FRSH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $838.81M | $720.42M | $596.43M | $498.00M |
Operating Income | $13.21M | $-138.61M | $-170.17M | $-233.37M |
Net Income | $183.72M | $-95.37M | $-137.44M | $-232.13M |
EPS (Diluted) | $0.63 | $-0.32 | $-0.47 | $-0.82 |
Total Assets | $1.60B | $1.61B | $1.46B | $1.38B |
Total Liabilities | $570.06M | $473.96M | $384.51M | $328.40M |
Cash & Equivalents | $569.77M | $620.32M | $488.12M | $304.08M |
Free Cash Flow OCF − CapEx | $236.67M | $151.47M | $84.11M | $-9.65M |
Shares Outstanding | 293.77M | 300.84M | 293.09M | 284.59M |